The global bioceramics market is estimated to be valued at USD 2,591.43 million in 2017, and is projected to reach USD 4,187.16 million by 2022, growing at a CAGR of 10.07% during the forecast period 2017-2022.
Bioceramics are biocompatible ceramic materials owing with properties like wear resistant, light weight. They are used in various applications, mostly for repair and replacement of diseased and damaged parts of the musculoskeletal system. The diverse properties of bioceramics help in a variety of applications in surgical implants, dental and bone implants, joint replacements, bone graft substitutes, dental implants, orthopedic load-bearing coatings, etc.
The global bioceramics market is primarily driven by factors, such as growing demand for medical services and devices, demand for biocompatible materials, the increased usage in dental care, growing usage in replacement of hard tissues of the body, the growing need to maintain healthy lifestyle and increasing need for implants. However, the bioceramics are not resilient, harder to fabricate and have inflammatory responses. These properties are offsetting the overall growth rate of the market by restricting the growth to a considerable extent.
Bioceramics market has been segmented on the basis of material types into aluminium oxide, zirconia, calcium phosphate, calcium sulfate, carbon, and glass; where XX is expected to dominate the global market accounting for over XX% in 2017. Alumina is used extensively in implants for dental and joint applications. Zirconia is also key ceramic material for bone implants; it is primarily used due to its chemical inertness and mechanical strength.
The bioceramics market has also been segmented on the basis of types, such as bioinert, bioactive, and bio-resorbable. Bioinert ceramics provides corrosion and wear-resistance and is typically used as structural-support implant, such as bone plates, bone screw, femoral heads. Bioactive ceramics are glass ceramics; dense non-porous glasses. Bio-resorbable ceramics are calcium phosphate, calcium sulphate, hydroxyapatite, tricalcium phosphate and ferric-calcium-phosphorous oxides. The bioceramics market has also been segmented on the basis of application into orthopaedic, bio-medical, and dental.
The market has also been segmented on the basis of geography into Asia-Pacific, North America, Europe, South America, and Middle-East and Africa. XX is the largest and the fastest growing market for bioceramics, occupying a major share of the total market. Positive outlook toward the orthopaedic sector in Germany is expected to drive market growth. In addition, the Asia-Pacific bioceramics market in the orthopaedic sector is also growing due to the rapidly expanding elderly population; the market in China is expected to witness strong growth in bioceramics market, as it is driven by the fact that people are gaining access to advanced medical treatment as healthcare reform reaches rural areas. North American bioceramics market is also expected to increase in terms of value due to research in bioceramics, increase in cancer incidences, growing prevalence of cardiovascular diseases in the United States and increasing funding and R&D activities in Canada.
Furthermore, the is an increasing demand of bioceramics due to its various uses in biomedical fields, advancements in medical technology and increasing demand for medical devices, dental crowns, bridges and bristles leading to the growth of the bioceramics market. In addition, due to the development of biomimetic composites and developing methods to produce customized nanoceramics, there is a constant increase in the demand for bioceramics which may result in higher growth rates leading to an increase in the bioceramics manufacturers.
Some of the major companies dominating this market are:
Kyocera Corp. CeramTec Morgan Advanced Materials Nobel Biocare etc.